Seasonal Allergic Rhinitis
📧 Sign up to get email alerts when something new happens for Seasonal Allergic Rhinitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-02-03Clinical Trial Update: A Study Comparing Two Fluticasone Furoate Nasal Sprays in the Relief of the Signs and Symptoms of Seasonal Allergic Rhinitis [Phase 3]
Phase 3 trial comparing two fluticasone furoate nasal sprays for seasonal allergic rhinitis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-01-29Clinical Trial Update: Dose Selection Study of Efficacy and Safety of Different Doses of Grass MATA MPL and Grass MATA Using mEECs™ [Phase 2]
Phase 2 dose-selection study evaluating different doses of Grass MATA MLP and Grass MATA using mEECs for efficacy and safety in seasonal all…
-
FDA approval · 2021-01-25FDA Approved: OLOPATADINE HYDROCHLORIDE — Supplemental Application (Alembic Pharmaceuticals Limited)
FDA approved Alembic Pharmaceuticals Limited's supplemental application for olopatadine hydrochloride (ANDA209420), authorizing changes unde…
-
FDA approval · 2020-11-24FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Torrent Pharmaceuticals Limited)
FDA approved Torrent Pharmaceuticals Limited's supplemental application for montelukast sodium. This action grants regulatory approval for c…
-
FDA approval · 2020-10-20FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Ajanta Pharma USA Inc.)
FDA approved Ajanta Pharma USA Inc.'s supplemental application for Montelukast Sodium, marking approval of a generic montelukast product und…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-10-09Clinical Trial Update: Allergic Rhinitis Changes the Sinus Microbiome [Phase 4]
Phase 4 trial exploring how allergic rhinitis affects the sinus microbiome, with completed results.
-
FDA approval · 2020-10-08FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Lannett Company, Inc.)
The FDA approved a supplemental application to allow Lannett Company, Inc. to market a generic Montelukast Sodium product (ANDA 200405).
-
FDA approval · 2020-10-05FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Torrent Pharmaceuticals Limited)
The FDA approved Torrent Pharmaceuticals Limited's supplemental application for montelukast sodium, authorizing the regulatory action for th…
-
CLINICAL_TRIALS trial_result · 2020-09-14Clinical Trial Update: Bepotastine Besilate-corticosteroid Nasal Spray Combination Compared to Placebo, Bepotastine Besilate Nasal Spray, and Corticosteroid Nasal Spray in the Treatment of Patients With Seasonal Allergic Rhinitis [Phase 2]
Phase 2 trial comparing a Bepotastine Besilate-corticosteroid nasal spray combination to individual components and placebo for seasonal alle…
-
CLINICAL_TRIALS trial_result · 2020-09-14Clinical Trial Update: Safety and Efficacy of Bepotastine Besilate Nasal Spray in the Treatment of Seasonal Allergic Rhinitis [Phase 2]
Phase 2 clinical trial update on safety and efficacy of Bepotastine Besilate Nasal Spray for seasonal allergic rhinitis.
-
CLINICAL_TRIALS trial_result · 2020-09-14Clinical Trial Update: Safety, Pharmacokinetics, and Efficacy of Bepotastine Besilate Nasal Product After Ragweed Pollen Exposure in an Environmental Chamber [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating safety, pharmacokinetics, and efficacy of a Bepotastine Besilate nasal product after ragweed pollen expo…
-
CLINICAL_TRIALS trial_result · 2020-09-14Clinical Trial Update: Bepotastine Besilate Nasal Sprays in the Treatment of Seasonal Allergic Rhinitis (SAR) [Phase 2]
Phase 2 clinical trial updates for Bepotastine Besilate nasal sprays evaluating efficacy in seasonal allergic rhinitis; results posted after…
-
FDA approval · 2020-09-04FDA Approved: MONTELUKAST SODIUM — Original Application (Amneal Pharmaceuticals LLC)
FDA approved Amneal Pharmaceuticals' Montelukast Sodium as a generic version of montelukast for the prevention and maintenance treatment of …
-
CLINICAL_TRIALS trial_result · 2020-08-19Clinical Trial Update: Clinical Equivalence Study of Mometasone Nasal Spray [Phase 3]
A Phase 3 clinical trial evaluating equivalence of mometasone nasal spray for seasonal allergic rhinitis has completed with results posted.
-
FDA approval · 2020-08-14FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Rising Pharma Holdings, Inc.)
The FDA approved a supplemental application for Montelukast Sodium from Rising Pharma Holdings, Inc. This action authorizes changes to the p…
-
CLINICAL_TRIALS trial_result · 2020-06-30Clinical Trial Update: A Dose-finding Study of ASP4070 [Phase 2]
This is a Phase 2 dose-finding study of ASP4070 for seasonal allergic rhinitis; results from the trial have been completed and posted.
-
FDA approval · 2020-02-24FDA Approved: ALLERGY RELIEF — Original Application (Publix Super Markets Inc)
FDA approved Publix Super Markets Inc's original application for a generic fexofenadine hydrochloride allergy relief product (brand name All…
-
FDA approval · 2019-11-08FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Ajanta Pharma USA Inc.)
FDA approved Ajanta Pharma USA Inc.'s supplemental application for montelukast sodium.
-
FDA approval · 2019-11-08FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Ajanta Pharma USA Inc.)
The FDA approved Ajanta Pharma USA Inc.'s supplemental application for Montelukast Sodium, enabling the generic montelukast product (ANDA 20…
-
FDA approval · 2019-11-08FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Ajanta Pharma USA Inc.)
FDA approves Ajanta Pharma USA Inc.'s supplemental application for Montelukast Sodium, updating regulatory status for the product.
-
FDA approval · 2019-11-05FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Rising Pharma Holdings, Inc.)
FDA approved a supplemental ANDA for montelukast sodium from Rising Pharma Holdings, enabling the marketing of a generic montelukast sodium …
-
CLINICAL_TRIALS trial_result · 2019-11-04Clinical Trial Update: Study of Efficacy and Safety of Omalizumab in Severe Japanese Cedar Pollinosis Adult and Adolescent Patients [Phase 3]
Phase 3 trial evaluating the efficacy and safety of omalizumab for severe Japanese cedar pollinosis (seasonal allergic rhinitis) in adults a…
-
FDA approval · 2019-10-18FDA Approved: ALLERGY RELIEF — Original Application (WALMART INC. (see also Equate))
The FDA approved Walmart's original application for an over-the-counter allergy relief product containing fexofenadine hydrochloride (Allerg…
-
CLINICAL_TRIALS trial_result · 2019-10-08Clinical Trial Update: Efficacy and Safety of GSP 301 Nasal Spray in Children (Aged 6 to Under 12 Years) With Seasonal Allergic Rhinitis (SAR) [Phase 3]
Phase 3 trial assessing efficacy and safety of GSP 301 nasal spray in children aged 6 to under 12 with seasonal allergic rhinitis; results p…
-
CLINICAL_TRIALS trial_result · 2019-09-20Clinical Trial Update: Onset of Action of Mometasone Furoate (MK-0887/SCH 032088) Nasal Spray Compared With Placebo in Seasonal Allergic Rhinitis (C93-184) [Phase 3]
Phase 3 clinical trial update comparing mometasone furoate nasal spray to placebo in seasonal allergic rhinitis; results posted in 2019.